Evidence map›Paper›PMID 39501386›Full record

ArticleJournal of medical case reports2024

Pleomorphic rhabdomyosarcoma of the adult bladder: a case report.

Yan-Kai Zeng, Kai-Yan Zhang, Jin-Chun Xing, Yi-Bin Li

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yan-Kai ZengDepartment of Urology and Center of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, China.
Kai-Yan ZhangDepartment of Urology and Center of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, China.
Jin-Chun XingDepartment of Urology and Center of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, China.
Yi-Bin LiDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, China. 51166415@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSarcomas with muscle differentiation (for example, rhabdomyosarcoma, leiomyosarcoma, and pleomorphic sarcoma) are uncommon in the adult bladder. CASE PRESENTATION: In this case report, we describe a 69-year-old Chinese male patient who presented to the urology outpatient clinic because of intermittent full-course macroscopic hematuria for 10 days. A B ultrasound indicated hypoechoic nodules in the right upper wall of the bladder. Transurethral resection of the bladder tumor and cystoscopic multipoint random biopsy was performed. Postoperative pathological findings showed pleomorphic rhabdomyosarcoma of the adult bladder. Later, he was transferred to the Department of Medical Oncology of our hospital for further postoperative chemotherapy. The chemotherapy regimen used was intravenous chemotherapy of dacarbazine with doxorubicin. The patient in this case has survived for 12 months postoperatively.

conclusionFrom this case, our elderly patient with early pleomorphic rhabdomyosarcoma of the urinary bladder received transurethral resection of bladder tumor and postoperative chemotherapy, and there had been no recurrence 12 months postoperatively. The aforementioned treatment modality may offer a favorable prognosis.

Indexed as

RhabdomyosarcomaUrinary Bladder NeoplasmsAgedAntineoplastic Combined Chemotherapy ProtocolsCystectomyDoxorubicinHematuriaHumansMaleTreatment OutcomeDoxorubicinCase reportChemotherapyPleomorphic rhabdomyosarcomaThe adult bladderTransurethral resection of bladder tumor (TURBt)

Identifiers

PMID39501386
PMCPMC11539568

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.